Receive The Newest Study Notifications

Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality innovative medicines for the treatment of oncology, autoimmune and other major diseases, today announced that the...

Patients will be recruited in North America, Europe, South America and the Asia Pacific region.  Debiopharm International SA (Debiopharm – www.debiopharm.com/debiopharm-international/), part of Debiopharm Group™, a Swiss-based global biopharmaceutical company, today...

Catalent Pharma Solutions, a global leader in clinical supply services, today announced that Eva Allen, Senior Clinical Supplies Manager, will present at the upcoming 10th Annual SCOPE Summit for Clinical Ops Executives at the Hyatt Regency Orlando Hotel, Orlando,...

Data to be presented at the 2019 Genitourinary Cancers Symposium  Pfizer Inc. (NYSE: PFE) and Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., "Astellas") announced today results from the Phase 3 ARCHES trial in men with metastatic...

GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on discovering and developing innovative gene therapies for retinal neurodegenerative diseases and central nervous system disorders, today announced publication of...

As scientific innovation leads to new trial designs, modern cloud technologies have enabled the industry to better manage how clinical trials are executed. Learn how new technologies can build a unified clinical landscape, making your clinical operations run more...

Diffusion Pharmaceuticals Inc. (Nasdaq: DFFN), a cutting-edge biotechnology company developing new treatments for life-threatening medical conditions by improving the body’s ability to bring oxygen to the areas where it’s needed most, today announced the presentation...

Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today the allowance of a new United States (US)...

Partnership enables complex trial designs for the development of novel therapies  4G Clinical today announced a partnership with Decibel Therapeutics to enable complex trial designs for the development of novel therapies for hearing and balance disorders. As part of...

New designation now includes all PNH patients  Apellis Pharmaceuticals Inc., (Nasdaq:APLS) a clinical-stage biopharmaceutical company focused on the development of novel therapeutic compounds to treat disease through the inhibition of the complement system, today...

Trialbee, a world leading technology provider in patient matching and engagement announces two commercial milestones with two of the top 10 pharma companies. Trialbee has been selected to accelerate the clinical development of new drugs through its patient recruitment...

Positive results of NuvOx Pharma’s NVX-208 in the treatment of stroke have been published at the International Stroke Conference. The randomized Phase Ib/II trial tested acute ischemic stroke patients given placebo or low, medium, or high doses of NVX-208. The primary...

Canada’s national life sciences venture, is pleased to announce an increased commitment to Sitka Biopharma with a $1.2M investment. This new investment will enable Sitka and its partner Cancer Research UK (CRUK) to accelerate critical development activities and...

Immunicum AB (publ) Announces First Patient Treated in Phase Ib/II ILIAD Combination Trial Immunicum AB (publ; IMMU.ST) announced today that the first patient has been treated in the Phase Ib/II ILIAD clinical trial. The trial will evaluate the safety and efficacy of...

– Phase 1 dose-escalation trial follows filing of IND in December 2018 – Exelixis, Inc. (Nasdaq: EXEL) today announced it is initiating phase 1 clinical development for XL092, the first internally-discovered Exelixis compound to enter the clinic following the...

Akex Keown writes:  Concerns over clinical trial transparency have been around for some time, but things are improving, particularly here in the United States as more companies embrace the idea. Thomas Wicks, chief strategy officer of New Jersey-based TrialScope, said...

Datatrak International, Inc. (OTC Markets: DTRK), a Software-as-a-Service (SaaS) provider and innovation leader of cloud-based technologies for the life sciences industry, today announced the first Electronic Data Capture (EDC) system to unify medical image capture,...

Study confirms significant results through 12 months of treatment with first personalized open-eye experience  A new, single center, prospective clinical study published in the January issue of Clinical Ophthalmology provides preliminary evidence that re-treatment...

Subject matter experts from CRF Bracket take an active thought-leadership role with key presentations and interactive roundtables at the conference Running a seamless clinical trial means improving not only data quality but also operational logistics and most...

RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) ("the Company" or "RegeneRx"), a clinical-stage drug development company focused on tissue protection, repair and regeneration, announced today that ReGenTree, LLC, a joint venture between GtreeBNT and RegeneRx, has...